World Cancer Day 2025: International Journal of Cancer
The International Journal of Cancer is a cancer journal from the Union for International Cancer Control covering experimental and clinical cancer research.
Related Articles
Preliminary Data Presented on Epoetin Alfa Dose Escalation With Stable Hydroxyurea for SCD Anemia | Docwire News
Preliminary efficacy and safety findings from a multicenter, open-label, phase Ib/II prospective study have been encouraging.
Efficacy of anti‐PD1 therapy in extranodal NK/T cell lymphoma: A matched cohort analysis from the LYSA
Click on the article title to read more.
The 5th Annual OncoAlert Colloquium
The Year in Review in Oncology 2024 brought to you by some of the Worlds TOP experts!
Tislelizumab Plus Chemotherapy Is Active, Tolerable in Advanced Gastric/GEJ Cancer
Tislelizumab plus irinotecan, paclitaxel, oxaliplatin, and 5-FU/leucovorin showcased encouraging efficacy and manageable safety in gastric/GEJ cancer.
Mayo Clinic on AE Management Strategies for EGFR-Mutated NSCLC
The combination of amivantamab plus lazertinib has emerged as a potential treatment option for patients with EGFR-mutated NSCLC and has shown sufficient efficacy responses.
Myasthenia Gravis Research Highlights: AAN 2024
Nicholas Silvestri, MD, of the Univ of Buffalo, provides an overview of the latest myasthenia gravis clinical research presented at AAN 2024.
Minimally Invasive Surgery Deemed Safe, Effective for “Oldest Old” Patients With Endometrial Cancer
Researchers found that robotic-assisted surgery, laparoscopic surgery, and vaginal surgery produced similar outcomes in patients who were 85 years of age or older.
Novel anti-HER2 ADCs vs dual anti-HER2 antibody for HER2-positive metastatic breast cancer failed to tyrosine kinase inhibitor
The aim of this study is to compare the efficacy and safety of a novel anti-HER2 antibody drug conjugate combined with HP (pertuzumab and trastuzumab)…
